exudative macular degeneration
Information
- Disease name
- exudative macular degeneration
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03803631 | Active, not recruiting | CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl) | April 4, 2018 | July 31, 2023 | |
| NCT01535950 | Completed | Phase 2 | Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD) | February 2012 | July 2013 |
| NCT01617148 | Completed | Phase 4 | Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept | June 2012 | December 2015 |
| NCT01674569 | Completed | Phase 1/Phase 2 | Pilot Study of X-82 in Patients With Wet AMD | October 2012 | February 2015 |
| NCT01835067 | Completed | Phase 2/Phase 3 | Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD | September 2014 | December 2019 |
| NCT02287298 | Completed | Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment | August 2014 | December 2015 | |
| NCT01473251 | Completed | N/A | Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration | November 2011 | April 2014 |
| NCT04504123 | Recruiting | Phase 2 | MMP-9 Inhibition for Recalcitrant Wet AMD | November 4, 2020 | March 1, 2024 |
| NCT05093374 | Recruiting | Phase 4 | Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting | March 1, 2021 | October 1, 2023 |